[
    [
        {
            "time": "",
            "original_text": "互动]贝达药业：在研新药BPI-D0316开展的一线、二线研究均有序推进中",
            "features": {
                "keywords": [
                    "贝达药业",
                    "BPI-D0316",
                    "新药研发",
                    "一线研究",
                    "二线研究"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "互动]贝达药业：在研新药BPI-D0316开展的一线、二线研究均有序推进中",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "从隐秘到胜出，解码红杉医疗投资版图",
            "features": {
                "keywords": [
                    "红杉资本",
                    "医疗投资",
                    "投资策略",
                    "行业布局"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "投资"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "从隐秘到胜出，解码红杉医疗投资版图",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]